Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients

Chinese Medical Journal

Volumn 119, Issue 23, 2006, Pages 1966-1971

  Zhang, Zi Ning ^a   Shang, Hong ^a   Jiang, Yong Jun ^a   Liu, Jing ^a   Dai, Di ^a   Diao, Ying Ying ^a   Geng, Wen Qing ^a   Jin, Xin ^a   Wang, Ya Nan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Activation analysis; Antiretroviral therapy; Highly active; Human immunodeficiency virus type 1; T lymphocytes

Indexed keywords

ANTIRETROVIRUS AGENT; CD38 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; HLA DR ANTIGEN; CHEMOKINE RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE ACTIVATION; MALE; PROTEIN EXPRESSION; UPREGULATION; VIRUS REPLICATION; CHINA; DRUG EFFECT; IMMUNOLOGY; MIDDLE AGED; PHYSIOLOGY; T LYMPHOCYTE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHINA; FEMALE; HIV INFECTIONS; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RECEPTORS, CHEMOKINE; T-LYMPHOCYTES;

EID: 33847165031     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200612010-00005     Document Type: Article

References (20)

1. Levacher M, Hulstaert F, Tallet S, Ullery S, Pocidalo JJ, Bach BA. The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value. Clin Exp Immunol 1992; 90: 376-382.
2. Phillips AN, Sabin CA, Elford J, Bofill M, Lee CA, Janossy G. CD8 lymphocyte counts and serum immunoglobulin A levels early in HIV infection as predictors of CD4 lymphocyte depletion during 8 years of followup. AIDS 1993; 7: 975-980.
3. + T cells correlate with plasma human immunodeficiency virus (HIV-1) RNA level in HIV-1 infection. J Infect Dis 1998; 178: 1279-1287.
4. + T-cell activation in HIV infection is antigenic stimulation. J Acquir Immune Defic Syndr 2000; 25: 203-211.
5. Mahalingam M, Peakman M, Davies ET, Pozniak A, McManus TJ, Vergani D. T cell activation and disease severity in HIV infection. Clin Exp Immunol 1993; 93: 337-343.
6. Savarino A, Bottarel F, Malavasi F, Dianzani U. Role of CD38 in HIV-1 infection: an epiphenomenona of T-cell activation of an active player in virus/host interactions. AIDS 2000; 14: 1079-1089.
7. Giovannetti A, Ensoli F, Mazzetta F, De Cristofaro M, Pierdominici M, Muratori DS, et al. CCR5 and CXCR4 chemokine receptor expression and β-chemokine production during earty T cell repopulation induced by highly active antiretroviral therapy. Clin Exp Immunol 1999; 118: 87-94.
8. Wang F, Jin L, Lei Z, Shi H, Hong W, Xu D, et al. Genotypes and polymorphisms of mutant CCR5-delta 32, CCR2-64I and SDF1-3' a HIV-1 resistance alleles in indigenous Han Chinese. Chin Med J 2001; 114: 1162-1166.
9. Chan CW, Cheng LS, Chan WK, Wong KH. Highly active antiretroviral therapy per se decreased mortality and morbidity of advanced human immunodeficiency virus disease in Hong Kong. Chin Med J 2005; 118: 1338-1345.
10. Powderly WG, Landay A, Lederman MM. Recovery of the immune system with antiretroviral therapy: the end of opportunism? JAMA 1998; 280: 72-77.
11. Hazenberg MD, Otto SA, van Benthem BH, Roos MT, Coutinho RA, Lange JM, et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 2003; 17: 1881-1888.
12. Giorgi JV, Hultin LE, McKeating JA, Johnson TD, Owens B, Jacobson LP, et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 1999; 179: 859-870.
13. Shang H, Zhang Z, Jiang Y, Han X, Wang Y, Zhang M, et al. Activation and coreceptor expression of T lymphocytes in HIV/AIDS patients of China. J Clin Immunol 2005; 25: 68-72.
14. + T-cell activation and senescence but not with lower effector memory T-cell function. Clin Immunol 2006; 120: 163-170.
15. + T-cell immunodeficiency is more dependent on immune activation than viral load in HIV-infected children on highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2006; 42: 269-276.
16. + T-cell surface CCR5 density as a cause of resistance to in vivo HIV-1 infection. J Acquir Immune Defic Syndr 2003; 34: 114-116.
17. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seventransmembrane, G protein-coupled receptor. Science 1996; 272: 872-877.
18. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996; 381: 661-666.
19. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998; 187: 875-883.
20. Ostrowski MA, Justement SJ, Catanzaro A, Hallahan CA, Ehler LA, Mizell SB, et al. Expression of chemokine reoeptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals. J Immunol 1998; 161: 3195-3201.